Selecting Patients Who May Benefit From Immunotherapy by Tissue-based Biomarkers.

NCT05593419 · clinicaltrials.gov ↗

UNKNOWN

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer Patients Received Immunotherapy

Interventions

DEVICE: TIIC signature

Sponsor

Peking University